Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Collard

Showing results (181-190 of 250) with videos related to

Pageof 25
Sort By:
Histopathology|February 12, 2019
Significance of bronchiolocentric fibrosis in patients with histopathological usual interstitial pneumoniaKiminobu Tanizawa, Brett Ley, Eric Vittinghoff, et al.
Chest|February 2, 2013
Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosisChristopher J Ryerson, Thomas Hartman, Brett M Elicker, et al.
Human Mutation|January 1, 1997
Mutations in purine nucleoside phosphorylase deficiencyM L Markert, B D Finkel, T M McLaughlin, et al.
Chest|February 21, 2023
Disparities in Antifibrotic Medication Utilization Among Veterans With Idiopathic Pulmonary FibrosisBhavika Kaul, Joyce S Lee, Laura A Petersen, et al.
The European Respiratory Journal|December 10, 2009
Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung diseaseE J Kim, B M Elicker, F Maldonado, et al.
The European Respiratory Journal|May 21, 2017
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosisHarold R Collard, Luca Richeldi, Dong Soon Kim, et al.
Neuroimage. Clinical|January 26, 2020
Absence of default mode downregulation in response to a mild psychological stressor marks stress-vulnerability across diverse psychiatric disordersJ van Oort, N Kohn, J N Vrijsen, et al.
Chest|February 23, 2017
Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity PneumonitisPing Wang, Kirk D Jones, Anatoly Urisman, et al.
Chest|June 11, 2019
Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary FibrosisGabrielle Y Liu, Iazsmin Bauer Ventura, Natalia Achtar-Zadeh, et al.
Respiratory Medicine|May 20, 2014
Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosisLuca Richeldi, Vincent Cottin, Kevin R Flaherty, et al.
Pageof 25

Showing results (181-190 of 250) with videos related to

Sort By:
Pageof 25
Histopathology|February 12, 2019
Significance of bronchiolocentric fibrosis in patients with histopathological usual interstitial pneumoniaKiminobu Tanizawa, Brett Ley, Eric Vittinghoff, et al.
Chest|February 2, 2013
Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosisChristopher J Ryerson, Thomas Hartman, Brett M Elicker, et al.
Human Mutation|January 1, 1997
Mutations in purine nucleoside phosphorylase deficiencyM L Markert, B D Finkel, T M McLaughlin, et al.
Chest|February 21, 2023
Disparities in Antifibrotic Medication Utilization Among Veterans With Idiopathic Pulmonary FibrosisBhavika Kaul, Joyce S Lee, Laura A Petersen, et al.
The European Respiratory Journal|December 10, 2009
Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung diseaseE J Kim, B M Elicker, F Maldonado, et al.
The European Respiratory Journal|May 21, 2017
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosisHarold R Collard, Luca Richeldi, Dong Soon Kim, et al.
Neuroimage. Clinical|January 26, 2020
Absence of default mode downregulation in response to a mild psychological stressor marks stress-vulnerability across diverse psychiatric disordersJ van Oort, N Kohn, J N Vrijsen, et al.
Chest|February 23, 2017
Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity PneumonitisPing Wang, Kirk D Jones, Anatoly Urisman, et al.
Chest|June 11, 2019
Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary FibrosisGabrielle Y Liu, Iazsmin Bauer Ventura, Natalia Achtar-Zadeh, et al.
Respiratory Medicine|May 20, 2014
Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosisLuca Richeldi, Vincent Cottin, Kevin R Flaherty, et al.
Pageof 25